COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage is low among adults so far this respiratory virus season (2024 to 2025).
Younger and middle-aged patients seem to be disproportionately affected by neurologic manifestations of postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection (Neuro-PASC).
For patients with unresectable locally advanced esophageal squamous cell carcinoma (ESCC), chemoradiotherapy (CRT) followed by immunochemotherapy (iCT) and then surgery is promising.
Adverse childhood experiences (ACEs) are common globally, according to a review published online Nov. 11 in JAMA Pediatrics. Sheri Madigan, Ph.D., from Universi ...